Pulse Biosciences (PLSE) Non Operating Income (2020 - 2026)
Pulse Biosciences (PLSE) posted quarterly Non Operating Income of $1.0 million for Q3 2025, up 2.67% year-over-year from $975000.0 in Q3 2024, and down 9.58% quarter-over-quarter from $1.1 million in Q2 2025.
Pulse Biosciences (PLSE) Non Operating Income (2020 - 2026) Analysis & Trends
Pulse Biosciences' Non Operating Income history runs 6 years deep, the most recent figure standing at $1.0 million for Q3 2025.
- In Q3 2025, Non Operating Income rose 2.67% year-over-year to $1.0 million; the TTM figure through Sep 2025 stood at $4.2 million (up 76.34% YoY), while the FY2024 annual figure was $2.7 million, up 95.89% from the prior year.
- Non Operating Income for Q3 2025 stood at $1.0 million, down from $1.1 million in the prior quarter.
- The five-year high for Non Operating Income was $1.2 million in Q1 2025, with the low at -$517000.0 in Q2 2021.
- The 5-year median for Non Operating Income is $330000.0 (2023), against an average of $349500.0.
- The sharpest annual moves came in 2022 and 2023: Non Operating Income sank 7433.33% in 2022, then surged 5000.0% in 2023.
- Pulse Biosciences' Non Operating Income stood at -$6000.0 in 2021, then tumbled by 7433.33% to -$452000.0 in 2022, then jumped by 232.74% to $600000.0 in 2023, then jumped by 44.67% to $868000.0 in 2024, then rose by 15.32% to $1.0 million in 2025.
- Business Quant data shows PLSE's Non Operating Income at $1.0 million in Q3 2025, $1.1 million in Q2 2025, and $1.2 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 82.70 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 25.45 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -160.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -12.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 3.50 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Pulse Biosciences | 3.50 Bn | 3.50 Bn | 161,000.00 | 615,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 615,000.00 |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.11 Mn |
| Mar 31, 2025 | 1.25 Mn |
| Dec 31, 2024 | 868,000.00 |
| Sep 30, 2024 | 975,000.00 |
| Jun 30, 2024 | 343,000.00 |
| Mar 31, 2024 | 478,000.00 |
| Dec 31, 2023 | 600,000.00 |
| Sep 30, 2023 | 686,000.00 |
| Jun 30, 2023 | 317,000.00 |
| Mar 31, 2023 | -239,000.00 |
| Dec 31, 2022 | -452,000.00 |
| Sep 30, 2022 | -14,000.00 |
| Jun 30, 2022 | 18,000.00 |
| Dec 31, 2021 | -6,000.00 |
| Sep 30, 2021 | -9,000.00 |
| Jun 30, 2021 | -517,000.00 |
| Mar 31, 2021 | -114,000.00 |
| Dec 31, 2020 | 6,000.00 |